Menu
GeneBe

CYP2R1

cytochrome P450 family 2 subfamily R member 1, the group of Cytochrome P450 family 2

Basic information

Region (hg38): 11:14877439-14892231

Links

ENSG00000186104NCBI:120227OMIM:608713HGNC:20580Uniprot:Q6VVX0AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • vitamin D-dependent rickets, type 1 (Supportive), mode of inheritance: AR
  • vitamin D hydroxylation-deficient rickets, type 1B (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Vitamin D hydroxylation deficient rickets, type 1BAREndocrineMedical treatment (eg, with supraphysiological levels of vitamin D3 or D2) has been reported to result in improvement or resolution of biochemical and clinical/radiographic anomaliesEndocrine8201479; 15128933; 22855339

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CYP2R1 gene.

  • not provided (108 variants)
  • Vitamin D hydroxylation-deficient rickets, type 1B (24 variants)
  • Inborn genetic diseases (15 variants)
  • not specified (2 variants)
  • Pulmonary disease, chronic obstructive, susceptibility to (1 variants)
  • CYP2R1-related condition (1 variants)
  • Vitamin D-dependent rickets, type 1 (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CYP2R1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
26
clinvar
1
clinvar
27
missense
1
clinvar
59
clinvar
2
clinvar
62
nonsense
4
clinvar
2
clinvar
1
clinvar
7
start loss
0
frameshift
4
clinvar
4
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
15
clinvar
1
clinvar
16
Total 8 3 61 43 2

Highest pathogenic variant AF is 0.000545

Variants in CYP2R1

This is a list of pathogenic ClinVar variants found in the CYP2R1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
11-14878128-T-C Likely benign (Nov 04, 2023)2693212
11-14878130-T-A Uncertain significance (Jul 11, 2022)2016123
11-14878146-G-A Likely benign (Jun 10, 2023)2042908
11-14878149-G-A Likely benign (Nov 21, 2023)3010938
11-14878176-C-T Likely benign (Nov 08, 2022)1938520
11-14878192-G-T Uncertain significance (Apr 17, 2022)2127312
11-14878201-T-A Uncertain significance (Mar 23, 2023)2580540
11-14878204-T-C not specified Uncertain significance (Dec 22, 2023)3079578
11-14878230-A-C Likely benign (Aug 19, 2022)2418462
11-14878231-A-G not specified Uncertain significance (Jun 18, 2021)2233339
11-14878234-A-C Low serum calcitriol Uncertain significance (-)1334316
11-14878264-C-T Vitamin D hydroxylation-deficient rickets, type 1B Uncertain significance (Feb 08, 2022)1391635
11-14878265-G-A Uncertain significance (Dec 21, 2023)1385510
11-14878277-C-T Uncertain significance (Oct 17, 2022)2138093
11-14878280-C-G Vitamin D hydroxylation-deficient rickets, type 1B Uncertain significance (Jul 13, 2022)1025990
11-14878287-A-G Likely benign (Jun 15, 2022)1991099
11-14878316-T-C Likely benign (Aug 30, 2023)1903764
11-14879094-C-G Likely benign (Oct 05, 2022)1959247
11-14879097-C-T Vitamin D hydroxylation-deficient rickets, type 1B Likely benign (Nov 04, 2023)1637925
11-14879098-G-A Benign (Jun 17, 2021)1561214
11-14879122-A-G Uncertain significance (Jul 27, 2023)3016792
11-14879141-T-C not specified Uncertain significance (May 31, 2023)2554404
11-14879146-G-C Uncertain significance (Nov 03, 2023)2964676
11-14879153-A-G not specified Uncertain significance (Dec 21, 2022)2263146
11-14879164-T-C Uncertain significance (Jun 22, 2022)2193872

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CYP2R1protein_codingprotein_codingENST00000334636 514246
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
3.79e-100.32712560401441257480.000573
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4812472690.9180.00001293284
Missense in Polyphen83116.680.711341441
Synonymous-0.4681061001.060.00000466969
Loss of Function0.8991721.50.7910.00000134249

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.002290.00227
Ashkenazi Jewish0.000.00
East Asian0.0006080.000598
Finnish0.00009260.0000924
European (Non-Finnish)0.0004550.000422
Middle Eastern0.0006080.000598
South Asian0.0003960.000392
Other0.0006730.000489

dbNSFP

Source: dbNSFP

Function
FUNCTION: Has a D-25-hydroxylase activity on both forms of vitamin D, vitamin D(2) and D(3). {ECO:0000269|PubMed:12867411, ECO:0000269|PubMed:15465040, ECO:0000269|PubMed:18511070}.;
Disease
DISEASE: Rickets vitamin D-dependent 1B (VDDR1B) [MIM:600081]: An autosomal recessive disorder caused by a selective deficiency of the active form of vitamin D (1,25-dihydroxyvitamin D3) and resulting in defective bone mineralization and clinical features of rickets. The patients sera have low calcium concentrations, low phosphate concentrations, elevated alkaline phosphatase activity and low levels of 25-hydroxyvitamin D. {ECO:0000269|PubMed:15128933, ECO:0000269|PubMed:25942481}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Steroid biosynthesis - Homo sapiens (human);Vitamin D Metabolism;Oxidation by Cytochrome P450;Metapathway biotransformation Phase I and II;Phase I - Functionalization of compounds;Metabolism of lipids;Vitamins;Cytochrome P450 - arranged by substrate type;Biological oxidations;Metabolism;Metabolism of steroids;Vitamin D (calciferol) metabolism;bile acid biosynthesis, neutral pathway;vitamin D<sub>3</sub> biosynthesis;Steroid hormones (Consensus)

Recessive Scores

pRec
0.189

Intolerance Scores

loftool
0.669
rvis_EVS
-0.09
rvis_percentile_EVS
46.92

Haploinsufficiency Scores

pHI
0.126
hipred
N
hipred_score
0.197
ghis
0.521

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.186

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Cyp2r1
Phenotype
liver/biliary system phenotype; homeostasis/metabolism phenotype;

Zebrafish Information Network

Gene name
cyp2r1
Affected structure
subcutaneous fat
Phenotype tag
abnormal
Phenotype quality
increased amount

Gene ontology

Biological process
organic acid metabolic process;vitamin metabolic process;xenobiotic metabolic process;response to cesium ion;response to ionizing radiation;calcitriol biosynthetic process from calciol;vitamin D metabolic process;exogenous drug catabolic process;oxidation-reduction process
Cellular component
cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle
Molecular function
iron ion binding;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;vitamin D3 25-hydroxylase activity